U.S. Advanced Wound Care Market Size, Share, & Trends Analysis Report By Product (Foam, Film, Hydrocolloid, Alginate), By Type (Chronic, Acute), By Region, Competitive Insights, And Segment Forecasts, 2019 - 2026

Published: Jul, 2019 | Pages: 86 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)

The U.S. advanced wound care market is expected to reach USD 3.42 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 4.2% over the forecast period. Rising number of surgeries and increasing incidence of chronic wounds in the U.S. are the key factors driving the market.

In the recent past, there has been a rise in the number of surgical procedures in the U.S. Rising prevalence of chronic diseases, such as cancer, diabetes, and autoimmune diseases, is one of the key factors leading to an increase in the number of surgeries being performed in the country. Incidence of infectious and non-communicable diseases has increased over the past few decades. This can be attributed to factors such as urbanization, borderline poverty in most developing states, antimicrobial resistance, and rise in prevalence of food-borne diseases. Unhealthy lifestyle, limited physical activity, alcohol abuse, and smoking are some of the major factors contributing to rising prevalence of the abovementioned diseases. According to CDC, in 2017, more than 100.0 million people were living with diabetes in the U.S.

Type II diabetes is the most common type of diabetes, and 90% of the affected population is suffering from type II diabetes. Diabetic foot ulcer, a common complication of diabetes, typically requires surgical intervention to prevent foot amputation. Thus, increasing number of surgeries is expected to drive growth of the advanced wound care market in the U.S. Cancer is a major healthcare burden in the U.S., as it is the second leading cause of death. According to CDC, about 1,658,716 new cases of cancer were reported in the U.S. in 2016. Therefore, these factors are likely to expedite market growth.

Further key findings from the report suggest:

• In terms of revenue, foam dressing segment held the largest share in 2018 owing to the rising incidence of chronic wounds

• In the application segment, chronic wound segment is expected to witness the fastest growth rate over the forecast period owing to rising incidence of diabetes in the U.S.

• Home healthcare segment is expected to witness fastest growth over the forecast period due to the increasing number of surgeries in the U.S.

• Prominent key players present in the U.S. advanced wound care market are Smith & Nephew, Molnlycke Health Care AB, and Baxter.

 Table of Contents

Chapter 1. Methodology
                  1.1 Research Methodology
                      1.1.1 Information procurement
                  1.2 Information or Data Analysis
                  1.3 Market Formulation and Validation
                      1.3.1 U.S. market: CAGR calculation
                  1.4 Segment Share Calculation
                  1.5 List of Secondary Sources

Chapter 2. Executive Summary
                  2.1 Market Outlook
                  2.2 Segment Outlook
                      2.2.1 Market segmentation
                  2.3 Competitive Insights
                  2.4 Market Snapshot

Chapter 3. U.S. Advanced Wound Care Market Variables, Trends, and Scope
                  3.1 Market Lineage Outlook
                      3.1.1 Parent market outlook
                      3.1.2 Ancillary market
                  3.2 Penetration and Growth Prospect Mapping
                  3.3 Product Pipeline Analysis
                  3.4 Regulatory Framework
                  3.5 Market Dynamics
                      3.5.1 Market driver analysis
                          3.5.1.1 Increasing incidence of chronic wounds
                          3.5.1.2 Increasing demand for reducing hospital stay
                          3.5.1.3 Rising number of surgeries
                      3.5.2 Market restraint analysis
                          3.5.2.1 Rising treatment cost
                  3.6 U.S. Advanced Wound Care Market Analysis Tools
                      3.6.1 SWOT analysis, by PEST
                      3.6.2 Porter's five forces analysis

Chapter 4. U.S. Advanced Wound Care Market: Segment Analysis, by Product, 2015 - 2026 (USD Million)
                  4.1 Definitions and Scope
                  4.2 Product Market Share Analysis, 2018 & 2026
                  4.3 Segment Dashboard
                  4.4 U.S. Advanced Wound Care Market, by Product, 2015 to 2026
                  4.5 Market Size Forecasts and Trend Analysis
                      4.5.1 Foam dressing
                          4.5.1.1 Foam dressing market, 2015 - 2026 (USD Million)
                      4.5.2 Hydrocolloid dressings
                          4.5.2.1 Hydrocolloid dressings market, 2015 - 2026 (USD Million)
                      4.5.3 Film dressings
                          4.5.3.1 Film dressings market, 2015 - 2026 (USD Million)
                      4.5.4 Alginate dressings
                          4.5.4.1 Alginate dressings market, 2015 - 2026 (USD Million)
                      4.5.5 Hydrogel dressings
                          4.5.5.1 Hydrogel dressings market, 2015 - 2026 (USD Million)
                      4.5.6 Collagen dressings
                          4.5.6.1 Collagen dressings market, 2015 - 2026 (USD Million)
                      4.5.7 Others 
                          4.5.7.1 Others market, 2015 - 2026 (USD Million)

Chapter 5. U.S. Advanced Wound Care Market: Segment Analysis, by End Use, 2015 - 2026 (USD Million)
                  5.1 Definitions and Scope
                  5.2 End-use Market Share Analysis, 2018 & 2026
                  5.3 Segment Dashboard
                  5.4 U.S. Advanced Wound Care Market, by End Use, 2015 to 2026
                  5.5 Market Size Forecasts and Trend Analysis
                      5.5.1 Hospitals
                          5.5.1.1 Hospitals market, 2015 - 2026 (USD Million)
                      5.5.2 Specialty clinics
                          5.5.2.1 Specialty clinics market, 2015 - 2026 (USD Million)
                      5.5.3 Home healthcare
                          5.5.3.1 Home healthcare market, 2015 - 2026 (USD Million)
                      5.5.4 Others
                          5.5.4.1 Others market, 2015 - 2026 (USD Million)

Chapter 6. U.S. Advanced Wound Care Market: Segment Analysis, by Application, 2015 - 2026 (USD Million)
                  6.1 Definitions and Scope
                  6.2 Application Market Share Analysis, 2018 & 2026
                  6.3 Segment Dashboard
                  6.4 U.S. Advanced Wound Care Market, by Application, 2015 to 2026
                  6.5 Market Size Forecasts and Trend Analysis
                      6.5.1 Chronic wounds
                          6.5.1.1 Chronic wounds market, 2015 - 2026 (USD Million)
                          6.5.1.2 Diabetic foot ulcers
                              6.5.1.2.1 Diabetic foot ulcers market, 2015 - 2026 (USD Million)
                          6.5.1.3 Pressure ulcers
                              6.5.1.3.1 Pressure ulcers market, 2015 - 2026 (USD Million)
                          6.5.1.4 Venous leg ulcers
                              6.5.1.4.1 Venous leg ulcers market, 2015 - 2026 (USD Million)
                          6.5.1.5 Other chronic wounds
                              6.5.1.5.1 Other chronic wounds market, 2015 - 2026 (USD Million)
                      6.5.2 Acute wounds
                          6.5.2.1 Acute wounds market, 2015 - 2026 (USD Million)
                          6.5.2.2 Surgical & traumatic Wounds
                              6.5.2.2.1 Surgical & traumatic wounds market, 2015 - 2026 (USD Million)
                          6.5.2.3 Burn wounds
                              6.5.2.3.1 Burn wounds market, 2015 - 2026 (USD Million)

Chapter 7. Wound Care Market: Competitive Analysis
                  7.1 Recent Development and Impact Analysis, by Key Market Participants
                      7.1.1 Key company market share analysis, 2018
                  7.2 Company Profiles
                      7.2.1 Smith & Nephew
                          7.2.1.1 Company overview
                          7.2.1.2 Financial performance
                          7.2.1.3 Product benchmarking
                          7.2.1.4 Strategic initiatives
                      7.2.2 Molnlycke Health Care AB
                          7.2.2.1 Company overview
                          7.2.2.2 Product benchmarking
                          7.2.2.3 Strategic initiatives
                      7.2.3 Acelity (KCI Licensing, Inc.)
                          7.2.3.1 Company overview
                          7.2.3.2 Product benchmarking
                          7.2.3.3 Strategic initiatives
                      7.2.4 ConvaTec Group PLC
                          7.2.4.1 Company overview
                          7.2.4.2 Financial performance
                          7.2.4.3 Product benchmarking
                          7.2.4.4 Strategic initiatives
                      7.2.5 Baxter
                          7.2.5.1 Company overview
                          7.2.5.2 Financial performance
                          7.2.5.3 Product benchmarking
                      7.2.6 Coloplast Corp.
                          7.2.6.1 Company overview
                          7.2.6.2 Financial performance
                          7.2.6.3 Product benchmarking
                      7.2.7 Medtronic
                          7.2.7.1 Company overview
                          7.2.7.2 Financial performance
                          7.2.7.3 Product benchmarking
                      7.2.8 3M
                          7.2.8.1 Company overview
                          7.2.8.2 Financial performance
                          7.2.8.3 Product benchmarking
                      7.2.9 Derma Sciences Inc. (Integra LifeSciences)
                          7.2.9.1 Company overview
                          7.2.9.2 Financial performance
                          7.2.9.3 Product benchmarking
                      7.2.10 Medline Industries, Inc.
                          7.2.10.1 Company overview
                          7.2.10.2 Product benchmarking

List of Tables

Table 1. U.S. advanced wound care market, by product, 2015 - 2026 (USD Million)
Table 2. U.S. advanced wound care market, by end use, 2015 - 2026 (USD Million)
Table 3. U.S. advanced wound care market, by application, 2015 - 2026 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing and forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation and validation
Fig. 8 U.S. advanced wound care market segmentation
Fig. 9 Market summary
Fig. 10 Market lineage outlook
Fig. 11 Penetration and growth prospect mapping
Fig. 12 Reimbursement pathway
Fig. 13 Market driver relevance analysis (current & future impact)
Fig. 14 Market restraint relevance analysis (current & future impact)
Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
Fig. 16 Porter's five forces analysis
Fig. 17 U.S. advanced wound care market: Product movement analysis
Fig. 18 U.S. advanced wound care market: Product scope and market share
Fig. 19 U.S. advanced wound care market product outlook: Key takeaways
Fig. 20 Foam dressing market, 2015 - 2026 (USD Million)
Fig. 21 Hydrocolloid dressings market, 2015 - 2026 (USD Million)
Fig. 22 Film dressings market, 2015 - 2026 (USD Million)
Fig. 23 Alginate dressings market, 2015 - 2026 (USD Million)
Fig. 24 Hydrogel dressings market, 2015 - 2026 (USD Million)
Fig. 25 Collagen dressings market, 2015 - 2026 (USD Million)
Fig. 26 Others market, 2015 - 2026 (USD Million)
Fig. 27 U.S. advanced wound care market: End-use movement analysis
Fig. 28 U.S. advanced wound care market: End-use scope and market share
Fig. 29 U.S. advanced wound care market end-use outlook: Key takeaways
Fig. 30 Hospitals market, 2015 - 2026 (USD Million)
Fig. 31 Specialty clinics market, 2015 - 2026 (USD Million)
Fig. 32 Home healthcare market, 2015 - 2026 (USD Million)
Fig. 33 Others market, 2015 - 2026 (USD Million)
Fig. 34 U.S. advanced wound care market: Application movement analysis
Fig. 35 U.S. advanced wound care market: Application scope and market share
Fig. 36 U.S. advanced wound care market application outlook: Key takeaways
Fig. 37 Chronic wounds market, 2015 - 2026 (USD Million)
Fig. 38 Diabetic foot ulcers market, 2015 - 2026 (USD Million)
Fig. 39 Pressure ulcers market, 2015 - 2026 (USD Million)
Fig. 40 Venous leg ulcers market, 2015 - 2026 (USD Million)
Fig. 41 Others market, 2015 - 2026 (USD Million)
Fig. 42 Acute wounds market, 2015 - 2026 (USD Million)
Fig. 43 Surgical and traumatic wounds market, 2015 - 2026 (USD Million)
Fig. 44 Burn wounds market, 2015 - 2026 (USD Million)
Fig. 45 Strategy framework
Fig. 46 Advanced wound management: Company share analysis